| Not Yet Recruiting | Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Smal Extensive-stage Small Cell Lung Cancer (ES-SCLC) | Phase 2 | 2026-04-01 |
| Recruiting | Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC Esophageal Squamous Cell Carcinoma, Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma Gastric Cancer, RCT | Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Inject Hematological Malignancies | EARLY_Phase 1 | 2026-02-01 |
| Not Yet Recruiting | Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection B Cell Malignancies | EARLY_Phase 1 | 2026-01-01 |
| Not Yet Recruiting | Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver M Lung Cancer (SCLC) | Phase 2 | 2025-12-25 |
| Not Yet Recruiting | Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Rando Esophageal Cancer (EsC) | Phase 3 | 2025-10-15 |
| Not Yet Recruiting | An Open-label, Single-arm Clinical Study of Stapokibart Injection in Combination with Tislelizumab Injection i Lung Cancer (NSCLC) | Phase 2 | 2025-10-01 |
| Not Yet Recruiting | Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer Esophageal Cancer, Head and Neck Cancer (H&Amp;Amp;Amp;N) | Phase 1 | 2025-09-01 |
| Completed | Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Ta ESCC | — | 2025-09-01 |
| Not Yet Recruiting | Lateral Positioning for Extubation After Adenotonsillectomy Perioperative Respiratory Adverse Events, Adenoidectomy, Tonsillectomy | N/A | 2025-08-20 |
| Recruiting | Oncolytic Virus in Esophageal Squamous Cell Carcinoma Esophageal Cancer | Phase 1 / Phase 2 | 2025-08-01 |
| Not Yet Recruiting | Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma (ESCC) | N/A | 2025-07-20 |
| Recruiting | Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma Neuroblastoma | EARLY_Phase 1 | 2025-07-18 |
| Not Yet Recruiting | The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy Esophageal Cancer | N/A | 2025-07-15 |
| Recruiting | Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung C Lung Cancer, Non-small Cell Lung Cancer | Phase 2 | 2025-07-04 |
| Recruiting | A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC Non-Small Cell Lung Cancer | Phase 2 | 2025-06-25 |
| Recruiting | Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies Malignant Tumors | Phase 1 | 2025-06-05 |
| Not Yet Recruiting | NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC Solid Tumor, Non Small Cell Lung Cancer | Phase 1 | 2025-05-01 |
| Recruiting | Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC Small Cell Lung Cancer Extensive Stage | Phase 1 | 2025-04-03 |
| Recruiting | Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT- Epilepsy (treatment Refractory) | N/A | 2025-02-28 |
| Recruiting | A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC Lung Cancer, Non-Small Cell | Phase 2 | 2025-02-01 |
| Recruiting | Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC Small Cell Lung Cancer | Phase 2 | 2025-02-01 |
| Not Yet Recruiting | Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of Extensive-stage Small-cell Lung Cancer | Phase 1 | 2025-01-10 |
| Recruiting | Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low Small Cell Lung Cancer Extensive Stage | Phase 2 | 2024-12-23 |
| Recruiting | Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma (ESCC), Neoantigen-loaded Dendritic Cell Vaccine, Immune Checkpoint Inhibitors (ICIs) | Phase 2 | 2024-10-01 |
| Not Yet Recruiting | The Effect of Aromatherapy for First Dental Visit Patients Dental Anxiety | N/A | 2024-09-20 |
| Recruiting | Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma | Phase 2 | 2024-06-30 |
| Completed | Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate C Metastatic Prostate Cancer | EARLY_Phase 1 | 2024-05-17 |
| Recruiting | Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC SCLC, Extensive Stage | Phase 1 / Phase 2 | 2024-05-16 |
| Not Yet Recruiting | Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC Pancreatic Cancer | Phase 1 | 2024-05-01 |
| Recruiting | Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer Esophageal Cancer | Phase 2 | 2024-05-01 |
| Recruiting | Effects of Aromatherapy on Anxiety and Pain During Dental Treatment in Adults Dental Anxiety | N/A | 2024-05-01 |
| Recruiting | Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lun NSCLC, Low Dose Radiotherapy, PD-1 Inhibitor | Phase 1 | 2024-04-25 |
| Recruiting | Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive Lung Cancer, Extensive-stage Small-cell Lung Cancer | Phase 1 / Phase 2 | 2024-04-18 |
| Recruiting | Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors Solid Tumor | Phase 1 | 2024-04-18 |
| Recruiting | Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer Pancreatic Cancer, Adjuvant Therapy | Phase 1 | 2024-04-01 |
| Recruiting | Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Lung Squamous Cell Carcinoma | Phase 2 | 2024-03-01 |
| Unknown | Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-02-29 |
| Not Yet Recruiting | HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis Peritoneal Metastases, Gastric Cancer | Phase 2 | 2024-02-20 |
| Not Yet Recruiting | Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer Gastric Cancer, Surgery, Anastomosis | N/A | 2024-02-01 |
| Unknown | Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum Laparoscopic Hepatectomy | EARLY_Phase 1 | 2024-02-01 |
| Unknown | Compared Unidirectional Valve Apparatus and Occluding the Non-ventilated Endobronchial Lumen for Lung Collapse Video-assisted Thoracoscopic Surgery, One-Lung Ventilation | N/A | 2024-01-25 |
| Recruiting | Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2024-01-01 |
| Unknown | Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases Malignant Peritoneal Effusion, Malignant Ascites, Serous Cavity Metastatises | Phase 1 | 2023-11-28 |
| Unknown | Immune Reconstitution After Allo-HSCT and Blinatumomab Leukemia, Lymphoid | — | 2023-10-01 |
| Not Yet Recruiting | Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC Combined Hepatocellular Cholangiocarcinoma | Phase 1 / Phase 2 | 2023-10-01 |
| Not Yet Recruiting | MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib GVHD, Acute Stem Cell Transplant Complications | Phase 2 | 2023-10-01 |
| Not Yet Recruiting | Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT Leukemia, Lymphoid | Phase 2 | 2023-10-01 |
| Recruiting | Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL Leukemia, Lymphoid | Phase 2 | 2023-09-10 |
| Unknown | Dead Mesenchymal Stem Cells for Radiation Lung Injury Radiation Lung Injury | Phase 1 / Phase 2 | 2023-09-10 |
| Recruiting | Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC Esophageal Squamous Cell Carcinoma (ESCC), Immunotherapy | Phase 2 | 2023-08-24 |
| Unknown | To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Adva Gastric Cancer | Phase 2 | 2023-07-01 |
| Unknown | Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Advanced Squamous Non-Small-Cell Lung Cancer | Phase 2 | 2023-07-01 |
| Unknown | Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies Myeloid Malignancies | Phase 2 | 2023-03-16 |
| Recruiting | Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC Extensive-stage Small-cell Lung Cancer | Phase 2 | 2023-03-07 |
| Recruiting | Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | 2022-12-22 |
| Completed | Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Glioblastoma Multiforme | — | 2022-11-22 |
| Unknown | CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma Multiple Myeloma | Phase 1 | 2022-09-21 |
| Unknown | ChiCGB vs BEAM in High-risk or R/R Lymphomas Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell | Phase 3 | 2022-07-01 |
| Unknown | MAP-guided Preemptive Therapy of aGvHD GVHD,Acute, Stem Cell Transplant Complications | Phase 2 | 2022-05-01 |
| Unknown | A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC Esophageal Squamous Cell Carcinoma | Phase 1 | 2022-04-01 |
| Unknown | Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors Carcinoma, Melanoma, Bladder Cancer | Phase 1 | 2022-03-01 |
| Unknown | Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation Hematologic Malignancy | Phase 1 / Phase 2 | 2022-03-01 |
| Recruiting | High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma Primary Central Nervous System Lymphoma (PCNSL) | Phase 2 | 2022-01-01 |
| Not Yet Recruiting | A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Po ALK Fusion Protein Expression, Adjuvant Therapy, Non-Small Cell Lung Cancer | Phase 2 | 2022-01-01 |
| Recruiting | Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy | Phase 1 | 2021-12-15 |
| Unknown | The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resecta Carrelizumab Plus Lenvatinib Combined With TACE, Borderline Resectable Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2021-09-01 |
| Completed | Effect of Lactulose and/or Polyethylene Glycol Solution for Bowel Preparation for Colonscopy Procedures Colonoscopy | Phase 3 | 2021-09-01 |
| Completed | Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer Carcinoma, Esophagus Cancer | Phase 1 | 2021-09-01 |
| Completed | Comparative Effect of Clear Aligner Mandibular Advancement and Twin Block Appliances in Class II Malocclusion CLASS II DIVISION 1 MALOCCLUSION | — | 2021-08-01 |
| Recruiting | Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors Peritoneal Carcinoma Metastatic, Pleural Effusion, Malignant, HER2 Positive Malignancies | EARLY_Phase 1 | 2021-03-12 |
| Completed | Effects of Spousal Participation in Breastfeeding Interventions at Different Perinatal Stages on Mothers' Copa Breast Feeding, Social Support, Coparenting | N/A | 2020-08-20 |
| Unknown | ATG-008 Combined With Toripalimab in Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2020-04-23 |
| Unknown | Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metast Gastroesophageal Junction Adenocarcinoma, Stomach Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma | Phase 2 | 2020-03-01 |
| Unknown | Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma Biliary Tract Adenocarcinoma | Phase 2 | 2019-12-01 |
| Unknown | Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus Unresectable Hepatocellular Cancer, Portal Vein Tumor Thrombus | Phase 1 / Phase 2 | 2019-12-01 |
| Recruiting | Personalized DC Vaccine for Postoperative Cancer Gastric Cancer, Hepatocellular Carcinoma, Non-Small-Cell Lung Cancer | Phase 1 | 2019-06-01 |
| Completed | Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer Non-squamous Non-small-cell Lung Cancer, Anlotinib | Phase 1 | 2019-04-30 |
| Completed | Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients Stage IV NSCLC | Phase 1 | 2019-01-18 |
| Unknown | Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma Hodgkin Lymphoma, Non-hodgkin Lymphoma | Phase 2 | 2019-01-01 |
| Unknown | Tofacitinib Combined With Chidamide in R/R ENKTCL Extranodal NK/T-cell Lymphoma | Phase 2 | 2019-01-01 |
| Unknown | Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT Leukemia, Acute, MDS | Phase 2 | 2019-01-01 |
| Unknown | Ruxolitinib Plus LVP in Patients With R/R ETP-ALL Acute T Cell Leukemia | Phase 1 / Phase 2 | 2018-12-01 |
| Unknown | A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients Non-small Cell Lung Cancer | — | 2017-11-23 |
| Unknown | Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma Lymphoma | Phase 2 | 2017-06-12 |
| Unknown | GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma Lymphoma, Extranodal NK-T-Cell | Phase 2 | 2017-06-01 |
| Unknown | Personalized DC Vaccine for Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 1 | 2016-11-30 |
| Unknown | A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer Cervical Cancer | N/A | 2016-10-01 |
| Completed | PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer Metastatic Non-small Cell Lung Cancer | Phase 1 | 2016-08-26 |
| Unknown | EpCAM CAR-T for Treatment of Advanced Solid Tumors Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M), Breast Cancer Recurrent, Gastric Cancer With Metastasis | Phase 1 | 2016-07-01 |
| Terminated | Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC Non-small Cell Lung Cancer Metastatic, EGFR Activating Mutation | Phase 4 | 2014-12-01 |
| Completed | Ecological Effect of Arginine Dentifrice on Oral Microbiota Dental Caries, Oral Bacterial Infection, Microbiota | N/A | 2013-10-01 |
| Completed | Phase I Trial of Emulsified Isoflurane Adverse Effect of Intravenous Anesthetics | Phase 1 | 2010-05-01 |
| Unknown | Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet Approaches Esophageal Cancer, Postoperative Complications, Diaphragm | Phase 3 | 2010-01-01 |
| Completed | Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena Pharyngitis | N/A | 2008-10-01 |
| Unknown | Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Contro Acute Schizophrenia | Phase 4 | 2008-08-01 |
| Completed | Hybrid-everted Versus Hand-sewn or Stapled Esophagogastrostomy in Prevention of Anastomotic Stricture Esophageal Neoplasms, Surgical Stomas | N/A | 2007-11-01 |
| Temporarily Not Available | The Change of Pulmonary Blood Flow During One Lung Ventilation One Lung Ventilation | — | — |